Chengdu

Edvantage Group (0382.HK) Announced Fourth Consecutive Positive Profit Alert Since Listing

Retrieved on: 
Monday, March 8, 2021

This is the Group's fourth consecutive positive alert since its listing.

Key Points: 
  • This is the Group's fourth consecutive positive alert since its listing.
  • The Group focuses on developing innovative and complex application talents equipped with global insights, and its schools' teaching modes of internationalisation and diversification have gained enormous popularity.
  • The Group believes the two schools in Chengdu, Sichuan can enhance its brand influence whilst achieving a huge synergy with Edvantage Group.
  • Edvantage Group Holdings Limited ("Edvantage Group" or the "Group", stock code: 0382.HK) is the largest private higher education group in the Guangdong-Hong Kong-Macao Greater Bay Area and an early mover in education sector in pursuing international expansion.

Chengdu During Spring Festival, a Beautiful City Full of Illuminations and Flowers

Retrieved on: 
Tuesday, February 9, 2021

A variety of illuminations and decorations seen everywhere in Chengdu, Sichuan, China creates a festive atmosphere for the coming Spring Festival 2021.

Key Points: 
  • A variety of illuminations and decorations seen everywhere in Chengdu, Sichuan, China creates a festive atmosphere for the coming Spring Festival 2021.
  • View the full release here: https://www.businesswire.com/news/home/20210208005964/en/
    Chengdu during Spring Festival, a Beautiful City Full of Illuminations and Flowers (Photo: Business Wire)
    As a comprehensive and continuous event in China, Spring Festival generally begins around the eighth day of the twelfth lunar month and ends on the fifteenth day of the first lunar month.
  • Originating from the ancient ritual for the new year, it is the biggest Chinese traditional festival, including rich historical and cultural heritages.
  • Among them, two points are the most eye-catching: First, Spring Festival stands for the arrival of the most beautiful season of the year, in which everything takes on a completely new look.

Digitalization helps Chengdu IFS secure growth amid COVID-19

Retrieved on: 
Wednesday, February 3, 2021

Chengdu International Finance Square (Chengdu IFS), the mega integrated shopping complex in Southwest China, has gained double-digit growth in traffic and sales for straight seven years despite disruptions wrought by the Covid-19 pandemic, per statistics the Chengdu IFS released for its brand renewal and seventh anniversary.

Key Points: 
  • Chengdu International Finance Square (Chengdu IFS), the mega integrated shopping complex in Southwest China, has gained double-digit growth in traffic and sales for straight seven years despite disruptions wrought by the Covid-19 pandemic, per statistics the Chengdu IFS released for its brand renewal and seventh anniversary.
  • Digital empowerment is crucial for this prestigious mall to secure robust growth amid the pandemic's uncertainties.
  • Chengdu IFS has been leveraging industry-leading approaches of digital empowerment and delicacy membership management to better connect brands with consumers.
  • Having acutely observed the prevailing trend, Chengdu IFS wasted no time in launching CHANNEL IFS, a broadcast-style mobile information platform that focuses on "what's trending".

More Patients Set to Benefit as Kanghong Pharmaceutical Targets New Indications with Conbercept

Retrieved on: 
Wednesday, February 3, 2021

CHENGDU, China, Feb. 3,2021 /PRNewswire/ -- Chengdu Kanghong Pharmaceutical Group ("Kanghong", SHE: 002773), has received Special Protocol Assessments from the Food and Drug Administration for three new indications for its biologic drug conbercept.

Key Points: 
  • CHENGDU, China, Feb. 3,2021 /PRNewswire/ -- Chengdu Kanghong Pharmaceutical Group ("Kanghong", SHE: 002773), has received Special Protocol Assessments from the Food and Drug Administration for three new indications for its biologic drug conbercept.
  • These new inclusions will potentially help over 21 million patients globally who suffered from DME , and approximately 28.06 million patients worldwide suffered from RVO .
  • Conbercept is a hallmark product that showcases the company's ability to bring innovative drugs to patients who need them.
  • The technology originated from the Israeli company IOPtima, acquired by Kanghong in 2017, of paramount importance for the internationalization of Kanghong.

Top Shopping Destination in Chengdu Leads “Culture of Cool” to Explore New Growth Opportunities

Retrieved on: 
Tuesday, February 2, 2021

Since its entry into Chengdu seven years ago, Chengdu IFS, occupying a prominent location in the citys bustling downtown scene, has committed to fostering the harmonious co-existence and inter-complementation between different cultural phenomena.

Key Points: 
  • Since its entry into Chengdu seven years ago, Chengdu IFS, occupying a prominent location in the citys bustling downtown scene, has committed to fostering the harmonious co-existence and inter-complementation between different cultural phenomena.
  • A key attribute of the Culture of Cool is its social feature.
  • Therefore, the prevailing trends behind pop-culture consumption are indispensable from Gen Zers shopping needs that are tightly associated with socializing and networking.
  • In 2020, the mall successfully launched the iconic CHAO, a dedicated space that gathers the in-trend elements of pop culture.

CF PharmTech and Chengdu Shangyi Launch the "Home-Based Recovery Program for Discharged Covid-19 Patients" and Announce Today's Global Release of the "R Plus Health" Free App

Retrieved on: 
Tuesday, February 2, 2021

Chengdu Shangyi Information Technology Co., Ltd is a professional IT service company in the healthcare industry in China.

Key Points: 
  • Chengdu Shangyi Information Technology Co., Ltd is a professional IT service company in the healthcare industry in China.
  • In April 2020, CF PharmTech and Chengdu Shangyi launched the "Home-Based Recovery Program for Discharged Covid-19 Patients".
  • The companies jointly launch the free "R Plus Health" App globally today.
  • The main function of the App is its remote intelligent cardiopulmonary/muscle/nutrition assessment, combining the wearable equipment with prepackaged medicinal supplements.

CF PharmTech and Chengdu Shangyi Launch the "Home-Based Recovery Program for Discharged Covid-19 Patients" and Announce Today's Global Release of the "R Plus Health" Free App

Retrieved on: 
Tuesday, February 2, 2021

Chengdu Shangyi Information Technology Co., Ltd is a professional IT service company in the healthcare industry in China.

Key Points: 
  • Chengdu Shangyi Information Technology Co., Ltd is a professional IT service company in the healthcare industry in China.
  • In April 2020, CF PharmTech and Chengdu Shangyi launched the "Home-Based Recovery Program for Discharged Covid-19 Patients".
  • The companies jointly launch the free "R Plus Health" App globally today.
  • Join the "R Plus Health" App to enhance physical fitness, improve immunity and fight against the coronavirus.

Senmiao Technology Announces Strategic Cooperation Agreement with Electric Vehicle Charging Operator Chengdu Xingchong

Retrieved on: 
Monday, February 1, 2021

CHENGDU, China, Feb.1, 2021 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao") (NASDAQ: AIHS), a provider of automobile transaction and related services targeting the online ride-hailing industry in China as well as an operator of its own online ride-hailing platform, today announced the signing of a strategic cooperation agreement with Chengdu Xingchong New Energy Technology Co., Ltd. ("Chengdu Xingchong"), a subsidiary of Star Charge.

Key Points: 
  • CHENGDU, China, Feb.1, 2021 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao") (NASDAQ: AIHS), a provider of automobile transaction and related services targeting the online ride-hailing industry in China as well as an operator of its own online ride-hailing platform, today announced the signing of a strategic cooperation agreement with Chengdu Xingchong New Energy Technology Co., Ltd. ("Chengdu Xingchong"), a subsidiary of Star Charge.
  • Star Charge is a leading electric vehicle ("EV") charging operator in China focused on the research & development and manufacturing of new EV charging equipment.
  • According to data released by the China Electric Charging Infrastructure Development Alliance, Star Charge had the second highest number of charging terminals in China as of December 2020.
  • Senmiao undertakes no obligation to publicly revise any forward-looking statements to reflect changes in events or circumstances.

Chengdu 2021 FISU World University Games Summer to Kick Off in Chengdu Soon

Retrieved on: 
Friday, January 29, 2021

At the same time, the aircraft features graphics of the World University Games, including colors that represent host city and good wishes for the success of the Chengdu 2021 FISU World University Games Summer.

Key Points: 
  • At the same time, the aircraft features graphics of the World University Games, including colors that represent host city and good wishes for the success of the Chengdu 2021 FISU World University Games Summer.
  • The 31st Summer World University Games is set to take place in Chengdu between August 18 and 29, which will feature 18 sports such as basketball, volleyball, track and field and swimming.
  • At present, there are only 200 days left until the opening of the Chengdu 2021 FISU World University Games Summer, which will be followed by around a dozen major events, including the 2022 World Table Tennis Championships, 2023 AFC Asian Cup and the 2025 World Games, among others.
  • Just as Juan Antonio Samaranch Jr. has predicted, "Chengdu is running toward the world, and the world is running into Chengdu".

Anticancer Bioscience Presenting at Biotech Showcase(TM) Digital 2021 Showcasing its Synthetic Lethal Precision Oncology Pipeline for the First Time

Retrieved on: 
Wednesday, January 13, 2021

Chengdu, China--(Newsfile Corp. - January 13, 2021) - Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced today announced that it is participating in Biotech Showcase Digital 2021, for the first time, providing an on-demand company presentation.

Key Points: 
  • Chengdu, China--(Newsfile Corp. - January 13, 2021) - Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced today announced that it is participating in Biotech Showcase Digital 2021, for the first time, providing an on-demand company presentation.
  • Anticancer Bioscience is participating in Biotech Showcase Digital 2021.
  • The Company will showcase its pioneering approach to precision oncology, and how it is applying its synthetic lethality expertise for better cancer therapies.
  • Pioneers in synthetic lethal approaches to precision oncology and experts in MYC biology and cell division, ACB was founded in 2016 in Chengdu, China.